Related Experiment Videos
[Autologous bone marrow transplantation in osteosarcoma]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 1, 1987
Summary
Intensive chemotherapy with autologous bone marrow transplantation (ABMT) shows promise for osteosarcoma patients. Early-stage treatment appears more effective, with patients remaining metastasis-free post-ABMT.
Area of Science:
- Oncology
- Hematology
Context:
- Osteosarcoma is a rare but aggressive bone cancer.
- Effective treatment strategies for advanced osteosarcoma remain a challenge.
Purpose:
- To evaluate the safety and efficacy of a high-dose chemotherapy regimen combined with autologous bone marrow transplantation (ABMT) in osteosarcoma patients.
Summary:
- Four osteosarcoma patients received a multi-drug high-dose chemotherapy regimen followed by ABMT.
- Two patients with advanced, metastatic disease showed limited response and disease progression.
- Two patients treated at an earlier stage for metastasis prevention are alive and disease-free at 31 and 18 months post-ABMT.
- The regimen was generally well-tolerated, with manageable side effects and no infectious complications during aplasia.
Impact:
- This intensive chemotherapy and ABMT approach appears safe and tolerable for osteosarcoma treatment.
- The findings suggest that this regimen may be particularly effective when administered in the non-metastatic phase of osteosarcoma, potentially preventing disease progression.